Biological vascular grafts.
Biological bypass graft material has been used as an alternative to autogenous vein since the first lower extremity revascularization procedures were performed. Both immunogenicity and biodegradation can contribute to the failure of these grafts and must be addressed. Cryopreservation at ultralow temperatures (-196 degrees C) after pretreatment with dimethylsulfoxide has been successful in preserving viable vein graft endothelium. Both rejection and deterioration of the cellular elements may contribute to the relatively high failure rates. The umbilical vein graft has become an effective alternative to autogenous material. The glutaraldehyde tanning procedure increases tensile strength, masks antigenicity, and sterilizes the tissue. Recent results with excellent 5-year patency (67%) and cumulative limb salvage (80%) confirm the utility of this graft.
Wengerter
K
K
Institute of Vascular Surgery, Englewood Hospital and Medical Center, NJ 07631, USA.
Dardik
H
H
D000818:Animals; D001705:Bioprosthesis; D015925:Cryopreservation; D006085:Graft Survival; D006801:Humans; D012501:Saphenous Vein / Q000637:transplantation*; D014184:Transplantation, Homologous / Q000009:adverse effects; D014471:Umbilical Veins / Q000637:transplantation*; D014654:Vascular Patency